CLEVELAND, Ohio —The top 10 medical innovations for 2011, to be announced this morning at the Clinic's eighth annual Innovation Summit, includes groundbreaking drugs for cancer, hepatitis and multiple sclerosis, as well as technical innovations like incision-less bariatric surgery.
"Hepatitis C protease inhibiting drugs: Two drugs awaiting approval, boceprevir and telaprevir, were developed specifically to target the hepatitis C virus and have shown a vast improvement over the cure rates of existing treatments".
Go to clevelandclinic.org/innovations for more information on the summit and the Clinic's top 10.
http://www.cleveland.com/healthfit/index.ssf/2010/11/2010
.
No comments:
Post a Comment